Washington Examiner
Sign in
SUBSCRIBE
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Linda Johnson

Linda Johnson

Read the latest stories and analysis from Linda Johnson.

This image provided by Pfizer Inc. shows a new print ad for Viagra, the world's top-selling erectile dysfunction drug. Executives at New York-based Pfizer hope the new ad campaign launching Tuesday, Sept. 30, 2014, which includes print ads in publications and a new 60-second television commercial, will nudge women to broach the subject with their mates. (AP Photo/Pfizer Inc.) Business

Viagra ads target women for 1st time

Linda Johnson · September 30, 2014 3:37 pm
FILE - In this Thursday, Feb. 28, 2013 file photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. The Food and Drug Administration on Thursday, Sept. 4, 2014 said it has granted accelerated approval to Merck's Keytruda, for treating melanoma that's spread or can't be surgically removed, in patients previously treated with another drug. (AP Photo/Matt Rourke, File) Business

FDA OKs Merck drug, 1st in new cancer drug class

Linda Johnson · September 4, 2014 9:41 pm
Business

Allergan reviews meeting requests in takeover bid

Linda Johnson · August 23, 2014 6:29 pm
Business

Allergan sues Valeant, claims fraud in buy attempt

Linda Johnson · August 1, 2014 9:32 pm
FILE - This April 20, 2010, file photo, shows an exterior view of Amgen offices in Fremont, Calif.  Biotech drugmaker Amgen Inc. reports quarterly earnings on Tuesday, July 29, 2014. (AP Photo/Paul Sakuma, file) Business

Biotech drugmaker Amgen laying off at least 2,400

Linda Johnson · July 29, 2014 11:17 pm
This May 4, 2014 photo shows the Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York. The pharmaceutical giant reports quarterly financial results on Tuesday, July 29, 2014. Business

Pfizer’s 2Q profit sinks 79 pct but tops forecasts

Linda Johnson · July 29, 2014 5:37 pm
In this Thursday, Feb. 28, 2013 photo, Merck scientist Pascale Nantermet conducts research to discover new HIV drugs in West Point, Pa. Merck reports quarterly financial results on Tuesday, July 29, 2014. (AP Photo/Matt Rourke) Business

Merck 2Q profit more than doubles

Linda Johnson · July 29, 2014 3:44 pm
FILE - This Oct. 16 2012, file photo, shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla. Johnson & Johnson reports qurterly financial results on Tuesday, July 15, 2014. (AP Photo/Chris O'Meara, File) Business

J&J 2Q profit climbs 13 percent on new-drug sales

Linda Johnson · July 15, 2014 4:27 pm
Business

Merck to pay $3.85B for hepatitis C drug developer

Linda Johnson · June 9, 2014 7:31 pm
FILE - In a Monday, April 5, 2010, file photo, Shane Nantz kicks up a cloud of pollen as he mows the front yard of his west Charlotte, N.C., home. Seasonal allergy sufferers can try newly FDA-approved types of immnotherapy, once-a-day tablets containing freeze-dried grass extract that dissolve quickly under the tongue, steadily lessening the excessive immune reaction much like the shots. (AP Photo/The Charlotte Observer, Todd Sumlin, File) Business

New allergy tablets offer alternative to shots

Linda Johnson · June 2, 2014 10:54 am
Business

Nonprescription Nexium heartburn medicine launches

Linda Johnson · May 27, 2014 6:28 pm
Business

Pfizer ups offer for AstraZeneca again, to $119B

Linda Johnson · May 19, 2014 4:06 am
Advertisement
  • 1
  • 2
  • 3
  • …
  • 10
  • ›Next page
Page 1 of 10
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement